Trexquant Investment LP - INOVIO PHARMACEUTICALS INC ownership

INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 203 filers reported holding INOVIO PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 1.42 and the average weighting 0.0%.

Quarter-by-quarter ownership
Trexquant Investment LP ownership history of INOVIO PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2021$510,000
+53.6%
102,300
+120.8%
0.03%
+23.1%
Q3 2021$332,000
-50.8%
46,326
-36.3%
0.03%
-58.1%
Q1 2021$675,000
+99.1%
72,714
-11.5%
0.06%
+67.6%
Q4 2017$339,000
-66.5%
82,124
-53.1%
0.04%
-57.5%
Q3 2015$1,012,000175,2240.09%
Other shareholders
INOVIO PHARMACEUTICALS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Defender Capital, LLC. 581,100$2,324,0002.21%
Round Table Services, LLC 339,391$1,358,0000.52%
ARK Investment Management 1,885,641$7,543,0000.31%
WASATCH ADVISORS LP 5,337,930$21,352,0000.28%
Cedar Brook Financial Partners, LLC 41,500$166,0000.10%
Unified Trust Company, N.A. 13,716$54,0000.05%
Virtus ETF Advisers LLC 60,398$242,0000.04%
OXFORD ASSET MANAGEMENT LLP 394,703$1,579,0000.04%
FOX RUN MANAGEMENT, L.L.C. 14,465$58,0000.03%
BREWIN DOLPHIN LTD 59,123$236,4920.03%
View complete list of INOVIO PHARMACEUTICALS INC shareholders